The NITI Aayog has promulgated a price range of Rs 300-500 for two Covid vaccines that would be available for the priority group at private facilities in the third phase of vaccination set to begin from March 1, sources privy to the development revealed, adding that the Bharat Biotech’s Covaxin would cost a bit higher.
However, the union health ministry would take a final call on the proposition.
The
proposed price has been floated after a five-hour long meeting held between the Dr VK Paul, member (health), NITI Aayog and officials from Serum Institute of India and Bharat Biotech on Friday evening, which was concluded around 11 pm., sources added.
"This would be the price the end-user would pay for a dose. It includes the service charge the private facilities can take from the beneficiaries," a top official said.
Which political party will win the Delhi Assembly polls to be held on Feb 5?